- Artikel
- Bron: Campus Sanofi
- 25 jun 2026
Chronic Rhinosinusitis with Nasal Polyps: The Interplay of Type 2 Inflammation and Smell Loss

Loss of the sense of smell is a major symptom of chronic rhinosinusitis with nasal polyps, affecting up to 90% of patients.1,2 Smell loss, which results in considerable lifestyle and psychological disease burden3, is a key indicator of type 2 inflammation4 and may be the first sign of the disease recurrence.1,2
Type 2 Inflammation and Loss of Smell |
- Loss of the sense of smell is one of the major symptoms of CRSwNP1,2
- It impacts patients QoL3, and may persist even after the surgery4
- Type 2 inflammation may play a role in yielding anosmia/hyposmia5
- It affects ≈90% of CRSwNP patients1
- Anosmia/hyposmia can be an early indicator of disease recurrence1,2
- Degree of type 2 inflammation is correlated with severity of impairment of smell1,2
Smell loss is associated with type 2 inflammation5–9 |

Smell loss represents a major burden for CRSwNP patients1,2 |

Reduced quality of life (HR-QoL)1,10

Daily activities are affected3

Depression, anxiety, phobia, irritation, fatigue etc.3

Altered interpersonal relationships11

Economic burden, decreased productivity12
Smell improvement as measure of disease control |
1 - International Guidelines
Emphasize the importance of the loss of the ability to smell as a treatment target13-14
2 - Assessment of olfaction
Is crucial for clinical evaluation of CRS1
3 - Management of smell loss
Is complex and requires a multifaceted approach19-21
1 - International Guidelines
Emphasize the importance of the loss of the ability to smell as a treatment target13-14
2 - Assessment of olfaction
Is crucial for clinical evaluation of CRS1
3 - Management of smell loss
Is complex and requires a multifaceted approach19-21
Abbreviations
CRS, chronic rhinosinusitis; CRSwNP, chronic rhinosinusitis with nasal polyps; HR-QoL, health-related quality of life; QoL, quality of life.
-
Yan X, et al. Laryngoscope Investig Otolaryngol. 2020;5(6):992-1002;
-
Rouyar A, et al. Allergy. 2019;74(3):549-559;
-
Mullol J, et al. J Allergy Clin Immunol Pract. 2022;10(6):1434-1453.e9;
-
Seys SF, et al. Allergy. 2020;75(11):2867-2878;
-
Dekeyser A, et al. Int J Mol Sci. 2024;25:4460;
-
Bachert C, et al. Front Immunol. 2024;15:1356298;
-
Lee K, et al. Int J Mol Sci. 2021;92:910;
-
Fokkens WJ, et al. Rhinology. 2020;58:1-464;
-
Stevens WW, et al. J Allergy Clin Immunol Pract. 2016;4:565-572;
-
Hopkins C, et al. Otolaryngol Head Neck Surg. 2024;170(4):1173-1182;
-
Patel ZM, et al. Int Forum Allergy Rhinol. 2022;12(4):327-680;
-
Schlosser RJ, et al. Int Forum Allergy Rhinol. 2017;7(1):50-55;
-
Fokkens WJ, et al. Rhinology. 2024;62(3):287-298;
-
Orlandi RR, et al. Int Forum Allergy Rhinol. 2021;11(3):213-739;
-
Rumeau C, et al. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(3):203-206;
-
Brumm MC, et al. Neurology. 2023;100(16):e1691-e1701;
-
Mullol J, et al. J Allergy Clin Immunol Pract. 2022;10(4):1086-1095.e5;
-
Doulaptsi M, et al. Clin Transl Allergy. 2018;8:32;
-
Marglani O, et al. J Asthma Allergy. 2023;16:1055-1063;
-
Senna G, et al. Multidiscip Respir Med. 2022;17(1):813;
-
Buchheit KM and Holbrook EH. Chronic rhinosinusitis with nasal polyposis: Management and prognosis. UpToDate. 2023. Available at UpToDate. Last accessed on 28 Aug 2024.
Neem contact op

MAT-BE-2600575 (v1.0) 04/05/2026